First-in-human phase I study of infusional and bolus schedules of Deflexifol, a novel 5-fluorouracil and leucovorin formulation, after failure of standard treatment
- Philip R. Clingan
- , Stephen P. Ackland
- , Daniel Brungs
- , Paul de Souza
- , Morteza Aghmesheh
- , Madhu B. Garg
- , Richard D. Ranson
- , Suzanne Parker
- , Rebecca Jokela
- , Marie Ranson
Research output: Contribution to journal › Article › peer-review
2
Citations
(Scopus)